A detailed history of Walleye Capital LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 15,000 shares of ABCL stock, worth $37,800. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,000
Previous 256,881 94.16%
Holding current value
$37,800
Previous $665,000 93.53%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$2.48 - $3.15 $599,864 - $761,925
-241,881 Reduced 94.16%
15,000 $43,000
Q3 2024

Nov 14, 2024

BUY
$2.39 - $3.49 $613,945 - $896,514
256,881 New
256,881 $665,000
Q2 2023

Aug 14, 2023

BUY
$5.66 - $7.59 $5,993 - $8,037
1,059 New
1,059 $6,000
Q2 2021

Aug 16, 2021

SELL
$20.19 - $34.17 $213,872 - $361,962
-10,593 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$23.29 - $53.2 $246,710 - $563,547
10,593 New
10,593 $360,000

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $719M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.